WEBINARS AND VIDEOS

• Smart Media Screening And Design: Saving Time And Boosting Titers

  Optimizing your cell culture media selection is crucial for clinical advancement. Learn how high throughput screening techniques accelerate media and feed optimization to significantly boost your biologics' titers.

• Practical Solutions For Protein Analytics And Residual DNA Testing

  Discover practical solutions for common quality control bottlenecks in biotherapy manufacturing. Learn how to improve protein analytics and DNA testing robustness and accelerate time to market.

• Cytovance And Thermo Fisher Scientific Single-Use Equipment Collaboration

  This video highlights the success Cytovance has had solving complex issues with our Thermo Scientific imPULSE Single-Use Mixers (S.U.M.s) HyPerforma Single-Use Fermentors (S.U.F.s) and BioProcess Containers (BPCs).

• HyPerforma DS 300 Single-Use Mixer Overview

  Watch this video to learn more about the Thermo Scientific HyPerforma Single-Use Mixer DS 300. This Modular mixing system offers a cost-effective, docking station-style mixing platform with multiple mixing-volume options.

• A Straightforward Path Toward Regulatory Compliance & Data Integrity With Your Microbial Testing Systems

  In this webinar, we will share a variety of strategies for implementing and validating microbial identification systems in the cGMP environment, possible difficulties along the way, and a comprehensive solution that addresses these challenges.

• Boosting Vaccine Yields Through Smarter Cell Culture Media Optimization

  Unlock efficient vaccine production by understanding how tailored peptone supplementation optimizes cell culture media, improving cell growth and overall yield across multiple critical cell lines.

• Driving Sustainability In Bioprocessing With Biobased Single-Use Solutions

  Discover how biobased materials in bioprocessing enable measurable carbon emission reductions. Learn practical strategies to meet decarbonization goals and adopt greener, operationally sound practices.

• Interview With Pharma Analytics Field Application Specialist - Sandi True

  Hear Sandi True, a Field Applications Specialist discuss helping customers navigate challenges often encountered when evaluating and implementing Residual DNA Quantitation, Mycoplasma Detection, and Microbial Identification Assays.

• Interview With Nico Chow And Sandi True, Field Applications Specialists

  Hear Nico Chow and Sandi True, Field Applications Specialists, discuss working with customers to help them evaluate and implement Residual DNA Quantitation, Mycoplasma Detection, and Microbial Identification Assays.

• Leveraging Single-Use Bioreactors In Bench-Scale Process Development

  Scaling bioprocesses requires matching critical variables to ensure consistent cell behavior and product quality. Optimize operations with efficient tools that enable more experiments per year.

• Dry Powder Media Manufacturing Grand Island Expansion

  Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.

• Accelerating Process Scale-Up From Benchtop To Commercialization- From Controller To Software

  Discover strategies for optimizing process control, refining media selection, and ensuring safety through rigorous contaminant detection to mitigate development risks.

• CaptureSelect™ Technology - Powerful Affinity For More Streamlined Purification

  Replace inefficient chromatographic steps with high-specificity affinity ligands to streamline downstream processing. This approach simplifies workflows and protects sensitive biomolecules.

• CaptureSelect Affinity Chromatography

  30-second video sharing a visualization of our CaptureSelect affinity chromatography capability. The target protein binds with VHH molecules immobilized on the chromatography beads, non-target proteins are removed, and the eluted fraction contains a high yield of purified target protein.

• Multi-Omics In Cell Culture Media Design

  Discussing the evolution of medium design for cell culture bioprocessing, and the role that multi-omics and bioinformatics can play in improved medium development.

• Supply Chain Efficiency And Sourcing In Gene Therapy

  An overview of the inbound supply chain in gene therapy and the process development challenges that are frequently faced. Learn about concepts such as scaling, cell culture media sourcing, mixing technologies, and configurable packaging.

• Inside Bioprocessing: Microbial Media

  Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.

• Basic Cell Culture Education Series: CHO Media

  This Knowledge Culture Basic Education Series on CHO media will explore CHO cells: their lineage, historical culture media, and process improvements. We will dive into how to optimize cell culture performance for superior outcomes.

• Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA

  In this webinar, we discuss pDNA purification, including how to identify optimal conditions for various chromatography media and optimize recovery and impurity removal.

• Cell Culture Media Manufacturing, Paisley, Scotland

  Learn more about our cell culture media manufacturing global network, including details of the Paisley, Scotland site's capacity expansion supporting the bioprocessing industry's rapidly growing needs.

• Cell Culture Media Manufacturing, Grand Island, NY

  Learn more about our cell culture media manufacturing global network, including details of the Grand Island, New York sites capacity expansion supporting the bioprocessing industrys rapidly growing needs.

• Future Proof Process Design Through Risk-Focused Decisions, Automation Readiness, And Regulatory Pragmatism

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene share that future proofing begins with deep process understanding.

• Streamlining Tech Transfer And Advancing Next Generation CAR T Therapies

  In this final segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene, Luman emphasizes that early engagement between R&D, process development, and manufacturing teams is critical for smooth tech transfer to CDMOs, including using scale-down models, documenting processes thoroughly, and collaborating closely with CDMO staff.

• Balancing Innovation And Flexibility In Early Cell Therapy Manufacturing Technologies

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene, Luman explains that introducing advanced analytics, automation, and digital tools early can strengthen process control and sterility, but startups must weigh innovation against practical constraints.

• The Importance Of Early Manufacturing Choices And Simple Flexible Process Design

  In this first segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene explore how early manufacturing decisions influence long-term success in cell therapy development.

• Why Academic Centers Reach The Clinic Faster

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene, Luman explains that academic institutions often move faster in Phase 1 because many trials are investigator-initiated, allowing streamlined oversight and quicker regulatory engagement, though similar pathways for sponsor-led programs don’t yet exist in the U.S. or EU.

• Early Development Choices Define Scalability And Product Quality In CGT

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene stress that early-stage process decisions have lasting downstream effects on product quality, scalability, and speed to clinic.

• Building Strong Data Foundations And Smart Logistics For Scalable CGT Development

  In this segment of Cell & Gene Live, Designing Early Manufacturing For Long-Term Success In CGT, Raymond Luke, Senior Director of MSAT at Verismo Therapeutics and Todd Luman, Executive Director of Process and Product Development at Allogene emphasize that early investment in analytics and structured data collection is essential to guide scale-up and regulatory success. 

• Supply Resiliency For Bioprocessing Amid Global Volatility

  Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.

• Streamlining Vaccine Purification: Techniques For Modern Modalities

  Explore cutting-edge chromatography techniques accelerating vaccine purification across diverse modalities, with case studies on HPV, Malaria, and COVID-19.

• Scaling Plasmid DNA Production: A Proven Strategy For Higher Yields

  Learn how an agile manufacturing partner scaled their plasmid DNA production and achieved higher yields by optimizing their media selection and fermentation processes.

• Next-Gen Disease Models And Cell Therapeutics: Innovations In AI, Omics And Collaboration

  Learn how to leverage AI, omics integration, and collaborative research to build more physiologically relevant disease models and accelerate the development of next-gen cell therapies.

• Discover The Benchtop DynaDrive Single-Use Bioreactor

  Ready to transform your process development? Introducing the 5 L Thermo Scientific DynaDrive Single‑Use Bioreactor (S.U.B.), now available! Experience the same bioreactor design from bench to commercial and re‑imagine scalability in process development.

• Efficient Scale-Up Of Monoclonal Antibody Production: From Bench Top To 500L

  Scaling monoclonal antibody production from the lab to a commercial scale can be challenging. Learn about an approach that helps you maintain consistent productivity and product quality across all scales.

• Achieving High Purity In Complex Antibody Formats

  Discover innovative purification strategies and workflow designs for next-generation antibody formats and learn to overcome challenges in achieving high purity and yield.

• Enhancing Protein Quality Through Optimized Galactosylation

  Advance your understanding of critical protein engineering. Explore expert strategies for optimizing complex molecular structures, paving the way for more effective and consistent biological products.

• Global Strategies For Resilience And Redundancy In Cell Culture Media Supply

  Ensure your cell culture media supply remains uninterrupted. Explore proactive strategies for global manufacturing equivalency and consistent media delivery.

• Tackling Residual DNA Testing In Biotherapy Manufacturing

  Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.

• Expanding Manufacturing Of Purification Resins To Align With Customer Demands

  Discover how scaling up processes and building out facilities has allowed for end-to-end solutions that meet customer requirements for both supply and quality in their production lines.

• Ensuring Quality, Driving Customer Confidence

  How does quality assurance help drive scientific progress? A 30-year veteran shares her story of supporting customer needs and the development of groundbreaking new therapeutics.

• An Innovative Approach To High Aggregate Challenges

  In this webinar, hear from a technical specialist on addressing the challenges with antibody aggregates and process related impurity removal using a new high performance chromatography resins

• Enhancing Aseptic Fill-Finish Processes

  Achieve exceptional product recovery and sterility. Learn about high-integrity surge bags, advanced leak detection, and flexible design options for your fill-finish applications.

• CAR-T Innovation: Balancing Allogeneic And Autologous Cell Therapy

  Join experts as they discuss strategies for optimizing allogeneic and autologous therapies, aiming for balanced development and wider patient accessibility by 2030.

• Efficient AAV Purification With AAVx And AAV9 Magnetic Beads

  Explore an alternative to chromatographic affinity capture that eliminates the need for universal nuclease treatment by utilizing magnetic beads with ligands specific to AAV.

• Efficient-Pro Medium And Feed (Why Choose Pro)

  Discover an animal-origin-free and chemically defined medium and feed system solution designed to revolutionize your workflow.

• Advancing Vaccine Development With Novel Chromatography Solutions & Quality Testing

  Learn more on novel chromatography solutions that can help improve the downstream processes of different vaccine types such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs).

• Developing A 2-Step Chromatographic Process For The Purification Of AAV Vectors

  POROS CaptureSelect AAVX and POROS 50 HQ were tested for capture and polishing, respectively, of AAV2, AAV9 and a novel engineered capsid to achieve vectors with high purity and significant empty: full ratio improvement.

• Scalable Purification Of In Vitro Transcribed mRNA

  Learn more about how affinity-based mRNA chromatography resin facilitates the purification and isolation of mRNA from in vitro transcription (IVT) manufacturing processes.

• Manufacturing Considerations For Viral & Non-Viral Platform Selection

  In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.

• POROS Chromatography Technology

  These rigid, chemically stable polymeric beads enable high throughput and resolution, delivering higher product yield and purity by improving mass transfer and allowing fast flow rates.